ClinicalTrials.govpublic full text
Optimization for Regorafenib in HCC
hepatocellular carcinoma, liver cancer, hcc, regorafenib, sorafenib, stivarga, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 911847
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.